Table 3.
Significant clinical correlations with AAB/IgG ratios after BH-correction in patients with infection-triggered onset (Spearman correlation coefficient and Benjamini–Hochberg corrected p-value; significant correlations marked with asterisks: * p < 0.05, ** p < 0.01).
| alpha1-AdR-AAB/IgG | alpha2-AdR-AAB/IgG | beta1-AdR-AAB /IgG | M3-AChR- AAB /IgG |
M4-AChR- AAB/IgG |
AT1-R- AAB/IgG |
ETA-R- AAB/IgG |
|
|---|---|---|---|---|---|---|---|
| Fatigue | r: 0.383 p: 0.004 ** |
r: 0.363 p: 0.009 ** |
r: 0.331 p: 0.045 * |
r: 0.234 p: 0.280 |
r: 0.349 p: 0.028 * |
r: 0.317 p: 0.035 * |
r: 0.328 p: 0.017 * |
| Muscle pain | r: 0.482 p: <0.001 ** |
r: 0.471 p: <0.001 ** |
r: 0.310 p: 0.045 * |
r: 0.386 p: 0.008 ** |
r: 0.319 p: 0.035 * |
r: 0.427 p: 0.002 ** |
r: 0.429 p: 0.001 ** |
| Cognitive score | r: 0.152 p: 0.303 |
r: 0.144 p: 0.306 |
r: 0.209 p: 0.132 |
r: 0.095 p: 0.583 |
p: 0.084 p: 0.589 |
r: 0.290 p: 0.051 |
r: 0.371 p: 0.007 ** |
| Bell Score | r: −0.244 p: 0.099 |
r: −0.223 p: 0.105 |
r: −0.154 p: 0.270 |
r: −0.196 p: 0.280 |
r: −0160 p: 0.308 |
r: −0.250 p: 0.083 |
r: −0.273 p: 0.045 * |
| COMPASS 31 pupillomotoric score | r: 0.268 p: 0.082 |
r: 0.212 p: 0.123 |
r: 0.215 p: 0.132 |
r: 0.166 p: 0.298 |
r: 0.294 p: 0.042 * |
r: 0.084 p: 0.590 |
r: 0.039 p: 0.791 |